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Available online 23 November 2015Bone-marrow derived vascular precursors are an important endogenous repair reservoir for vascular repair and
neovascularization [1]. Therapies of stem/progenitor cells targeting on angiogenesis are considered hopeful solu-
tions for tissue repair and regeneration. However, the dysfunction of patient-derived progenitor cells has been
implicated in diabetes [2], which limited the efﬁcacy of autologous cell therapies in the clinic [3,4]. MicroRNAs
are important gene regulatorswhose functions remain largely unknown. In this project we reported the different
microRNA expression proﬁles in bone marrow-derived progenitor cells from type 2 diabetic mice and their nor-
mal controls using microRNA array analysis. All microarray data are available at the Gene Expression Omnibus
(GEO) at NCBI (http://www.ncbi.nlm.nih.gov/geo), under accession number GSE72616.
© 2015 Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Speciﬁcationsrganism/cell
line/tissueMouse bone marrow cellsex Male
equencer or
array typeMicroRNA microarray (μParaﬂo® Biochip Technology)ata format Raw
xperimental
factorsBone marrow cells cultured in endothelial growth medium-2
for 7 daysxperimental
featuresBone marrow cells were isolated from type 2 diabetes mice
(db/db) and their normal control litters (db/+). The cells
were cultured in endothelial growth medium-2 for 7 days.
Total RNA was extracted and subjected to microRNA analysis.onsent Not required.
mple source
locationN/A.1. Direct link to deposited data
http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE72616
2. Experimental design, materials and methods
2.1. Animals
Male db/db (BKS.Cg-m+/+Leprdb/J) mice and their healthy control
litters (BKS.Cg-m−/− Lepdb/− lean, db/+) at the age of 10–12 weeksen access article under the CC BY-NCwere purchased from the Jackson Laboratory (Bar Harbor, ME). The
animals were maintained under controlled environmental condition
(12 h: 12 h light/dark cycle, temperature approximately 25 °C), and
providedwith standard laboratory food andwater ad libitum. All animal
procedures were performed according to Wayne State University
Institutional Animal Care and Use Committee (IACUC) guidelines.3. Bone marrow-derived progenitor cell culture
The important roles of bone marrow-derived progenitor cells have
been demonstrated in previous reports [1,2]. However, they were
found dysfunctional in diabetes [3,4]. To study the microRNA proﬁle of
bone marrow-derived progenitor cells, bone marrow mononuclear
cells were isolated from the tibias and femurs of mice (n = 3 each
group). The cells were plated on culture ﬂasks coated with rat plasma
vitronectin (Sigma-Aldrich) and maintained in Endothelial Growth
Media (EGM-2, Lonza) in 37 °C, 5% CO2. After 7 days of culture, the dif-
ferentiating bonemarrow-derived progenitor cells (BMPCs) aswe iden-
tiﬁed in previous reports [5,6] were used for experiments.3.1. MicroRNA array analysis
Total RNA was extracted from db/db BMPCs and db/+ BMPCs using
miRNeasyMini Kit (Qiagen). A total of 3 μg RNA each samplewas sent to
perform mouse genome-wide microRNA microarray analysis using
μParaﬂo® Biochip Technology (service provided by LC Sciences) based
on the latest version of the miRBase database (Sanger miRBase Release
21). In addition, multiple control probes are included in each chip-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
87J.-M. Wang, K. Zhang / Genomics Data 7 (2016) 86–87for quality controls of chip production, sample labeling and assay
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